Profile
ACRV NVO VRTX REGN SGEN ARGX
Company Name Acrivon Therapeutics, Inc. Common Stock Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $200.70M $456.40B $116.20B $80.34B $43.15B $35.73B
Employees 0.06K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Dr. Peter Blume-Jensen M.D., Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ACRV NVO VRTX REGN SGEN ARGX
Quant Rating Score 2 3 3 4 3 1
Quant Rating Sell Neutral Neutral Buy Neutral Strong Sell
Trading
ACRV NVO VRTX REGN SGEN ARGX
Last Close $6.5 $105.27 $451.23 $743.35 $228.74 $591.82
High 52 $10.54 $146.91 $516.74 $1201.76 $228.74 $602.47
Low 52 $3.4 $101.74 $392.81 $743.35 $228.74 $356.01
Price vs. 52 Week High -38.33 % -28.34 % -12.68 % -38.14 % 0 % -1.77 %
Price vs. 52 Week Low 91.18 % 3.47 % 14.87 % 0 % 0 % 66.24 %
Total Return
ACRV NVO VRTX REGN SGEN ARGX
1 Month Return -19.25 % -10.28 % -5.62 % -23.25 % 0 % 5.6 %
3 Month Return -29.27 % -22 % -7.18 % -37.29 % 0 % 12.62 %
6 Month Return -20.83 % -22.11 % 2.09 % -25.21 % 0 % 65.93 %
9 Month Return 71.05 % -12.95 % 7.53 % -21.99 % 0 % 47.97 %
YTD Return 32.11 % 1.76 % 10.9 % -15.36 % 0 % 55.57 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACRV NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.42 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -19.62 % 1.24 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 0.21 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
ACRV NVO VRTX REGN SGEN ARGX
Asset Growth -23.71 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth 51.05 % 32.32 % 9.25 % 6.49 % 22.93 % 190.7 %
Revenue Growth - 31.26 % 10.17 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year - 90.51 % 59.87 % 55.67 % 91.84 % 2074.24 %
Revenue 5 Year - 124.2 % 218.58 % 110.3 % 215.48 % 3040.37 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 494.04 % 9013.37 %
EBIT Growth -105.89 % 37.11 % -12.94 % -14.6 % 10.13 % 40.94 %
Net Income Growth -103.48 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share -975.3 % 106.79 % 34.59 % 13.48 % -764.83 % 63.97 %
Net Income 5 Yeari Growth Per Share -975.3 % 133.86 % 70.33 % 74.02 % -276.93 % -143.56 %
Net Income 10 Yeari Growth Per Share -975.3 % 98.61 % 809.6 % 871.12 % -624.16 % -857.4 %
Operating Income Growth -105.89 % 37.11 % -12.94 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) -41.58 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG -1337.31 % 118.29 % 9.63 % 76.95 % -148.34 % 21.62 %
Operating 5 Year CFG -1337.31 % 163.51 % 174.78 % 125.17 % -195.86 % -329.48 %
Operating 10 Year CFG -1337.31 % 150.92 % 6084.35 % 713.56 % -2622.09 % -1280.79 %
EPS Growth -102.96 % 52.28 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth -102.96 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share -29.41 % 29 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share 1461.07 % 75.22 % 104.06 % 137.56 % 33.92 % 93.95 %
Share Holder 5 Year Equity Growth Per Share 1461.07 % 121.9 % 291.14 % 219.1 % 220.81 % 318.67 %
Share Holder 10 Year Equity Growth Per Share 1461.07 % 49.62 % 1030.79 % 1286.9 % 691.19 % 3655.65 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth -6.39 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth -36.07 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
ACRV NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM 69.59 % 84.66 % 86.1 % 83.54 % 72.37 % 86.82 %
Return on Assets TTM -35.86 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -47.95 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -42.68 % 62.9 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 100 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 90.24 % 100.27 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM -4527.49 % 43.96 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM -1511.96 % 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM - 3.4 6.06 2.27 1.98 3.45
Payables Turnover TTM 0.38 1.72 3.73 4.58 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.76 0.65 0.91
Fixed Asset Turnover TTM 22.25 % 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 0.88 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -1.59 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -1.67 15.05 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 491.94 % 1681.3 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM -3220.54 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.1 % 56.7 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM -1511.96 % 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM -3.15 48.27 -99.85 23.78 -141.85 -169.15
Price To Operating Cash Flows Ratio TTM -4.07 28.12 -138.16 18.92 -203.89 -244.33
Price Cash Flow Ratio TTM -4.07 28.12 -138.16 18.92 -203.89 -244.33
Income Statement (TTM)
ACRV NVO VRTX REGN SGEN ARGX
Revenue $0B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $-0B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 0% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0.06B $114.63B $4.61B $4.65B $-0.62B $-0.22B
Net Income $-0.06B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -2.74 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
ACRV NVO VRTX REGN SGEN ARGX
Long Term Debt $0B $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $0.02B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.12B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0.09B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.14B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
ACRV NVO VRTX REGN SGEN ARGX
Net Income $-0.06B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.04B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.34
ABCL AbCellera Biologics Inc. 2.725
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.92
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.28
ABSI Absci Corporation 2.645
ABUS Arbutus Biopharma Corporation 3.495
ABVC ABVC BioPharma, Inc. 0.5351
ABVX Abivax SA American Depositary Shares 8.69
ACAD ACADIA Pharmaceuticals Inc. 16.145
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 0.9492
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.055
ACHV Achieve Life Sciences, Inc. 4.33
ACIU AC Immune SA 3.2599
ACLX Arcellx, Inc. 88.79
ACST Acasti Pharma Inc. 3.37
ACXP Acurx Pharmaceuticals, Inc. 1.3001
ETFs With Exposure to ACRV
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.0025 234.44
VTI Vanguard Total Stock Market Index Fund 0 294.3
SCHB Schwab U.S. Broad Market ETF 0.000454367 23.051
SCHA Schwab U.S. Small-Cap ETF 0.00262412 27.355
IWN iShares Russell 2000 Value ETF 0.00565 175.56
IWO iShares Russell 2000 Growth ETF 0.00305 304.2
VXF Vanguard Extended Market Index Fund 0 200.195
HDG ProShares Hedge Replication ETF 0.000428891 50.1023
UWM ProShares Ultra Russell2000 0.000990341 47.6
VTHR Vanguard Russell 3000 Index Fund 0 264.025
IWC iShares Micro-Cap ETF 0.01862 132.56
URTY ProShares UltraPro Russell2000 0.000440802 60.1058
VTWV Vanguard Russell 2000 Value Index Fund 0.01 154.58
VTWO Vanguard Russell 2000 Index Fund 0 94.86
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 101.57
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 101.55
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 50.37
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 50.36
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.36
RYLD Global X Russell 2000 Covered Call ETF 0 16.5121
DFAT Dimensional U.S. Targeted Value ETF 0.00010241 59.17
DFAS Dimensional U.S. Small Cap ETF 0.00021028 68.655
DFAC Dimensional U.S. Core Equity 2 ETF 0.00010342 35.71
VTSAX Vanguard Total Stock Market Index Fund 0 142.62
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 149.17
VITSX Vanguard Total Stock Market Index Fund 0 142.64
DFSU Dimensional US Sustainability Core 1 ETF 0.00096602 38.66
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000104799 101.09
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 149.17
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00356256 37.76
AVSC Avantis U.S. Small Cap Equity ETF 0.01 57.42
VEMPX Vanguard Extended Market Index InstlPlus 0 368.12
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 267.57
RSSL Global X Funds 0 90.8185
DXUV Dimensional ETF Trust 0.00003475 54.54
RFLR Innovator ETFs Trust 0.02 26.6796
Unlock